Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Neovasc Inc.
NVCN
Healthcare
Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter...
treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:NVCN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(8)
•••
Monty2469
X
View Profile
View Bullboard History
Comment by
Monty2469
on Mar 07, 2022 3:14pm
RE:Class action
you may have likely seen this since... https://neovasc.com/newsreleases/neovasc-announces-complete-dismissal-of-securities-class-action-complaint-with-prejudice/
(3018)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Feb 04, 2022 9:09am
Neovasc Reducer™ Demonstrates Cost Savings
VANCOUVER and MINNEAPOLIS, Feb. 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced the publication of
...more
Access North American AND Australian listed and Pre-IPO opportunities – here!
posted Dec 27, 2024 9:00am by
Stockhouse Publishing Ltd.
-
|
For the first time on Stockhouse, Canadian investors can access ASX-listed opportunities through our partnership with HotCopper in Australia, opening doors to high-potential investments at the click of a button. Learn more here… ...read more
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Aug 30, 2021 9:15pm
Class action
Anyone know of any updates on the proposed class action against Neovasc for the shoddy FDA application?
(3018)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Aug 17, 2021 9:19am
Submission of COSIRA-II Protocol Supplement to FDA
VANCOUVER and MINNEAPOLIS, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has filed a
...more
(8)
•••
Dalahlama
X
View Profile
View Bullboard History
Post by
Dalahlama
on Apr 16, 2021 12:35pm
Time to Buy!
Any price below a dollar is a steal for this stock. At current levels it's a no brainer!
(5)
•••
SmallCapPaul
X
View Profile
View Bullboard History
Post by
SmallCapPaul
on Dec 29, 2020 10:58am
2020 Rearview Mirror - Worthwhile
CC is usually good for uncommon insight https://www.channelchek.com/news-channel/What_Do_Investors_Look_At_
(9)
•••
schoolofrock
X
View Profile
View Bullboard History
Post by
schoolofrock
on Dec 11, 2020 11:34am
Virtual Road Show replay for those who missed it (Dec 8th)
"We hope you found the presentation and Q&A session informative and enjoyable. You can watch the replay, and find analyst Ahu Demir's research on Neovasc on Channelchek.com, at no cost
...more
(9)
•••
schoolofrock
X
View Profile
View Bullboard History
Post by
schoolofrock
on Dec 08, 2020 7:53am
Virtual Road Show with Neovasc President & CEO Fred Colen
Today @ 1pm (Eastern) - Virtual Road Show with Neovasc President & CEO, Fred Colen. Info at https://www.channelchek.com/news-channel/Channelchek_Virtual_Road_Show_Series
(14)
•••
Havefun123
X
View Profile
View Bullboard History
Comment by
Havefun123
on Oct 27, 2020 9:34pm
RE:RE:Such a weird stock
Seems like it's going to be very ugly tomorrow
(105)
•••
mjh9413
X
View Profile
View Bullboard History
Comment by
mjh9413
on Oct 27, 2020 3:44pm
RE:Such a weird stock
FDA meeting is/was scheduled for TODAY. last few days indicate it is not meant to end totally positively. eom
(14)
•••
Havefun123
X
View Profile
View Bullboard History
Post by
Havefun123
on Oct 24, 2020 3:45pm
Such a weird stock
For the last couple months, every time it started trending up, it went down even harder. Was there suppose to be some vote for FDA approval in Nov?
(5)
•••
SmallCapPaul
X
View Profile
View Bullboard History
Post by
SmallCapPaul
on Aug 10, 2020 11:38am
Lots of Near-Term Catalysts
Reducer EU revenues declined due to COVID-19 https://www.channelchek.com/news-channel/Neovasc__NVCN___NVCN_CA____Q2_EPS_Preview__Lots_of_Near_Term_Catalysts
(196)
•••
bobus99
X
View Profile
View Bullboard History
Post by
bobus99
on Jun 17, 2020 8:02pm
suspecious
i am suspecting this will go above 52 week high in less than 30 days
(1)
•••
mcdotca
X
View Profile
View Bullboard History
Post by
mcdotca
on Jun 12, 2020 11:07am
180 Days from PMA Submission
I'm not sure how much Covid has or will impact the standard review process of the PMA application but I've read that the FDA requires 180 days. It was accepted for review Jan 15 so we should
...more
(340)
•••
nrv090909
X
View Profile
View Bullboard History
Post by
nrv090909
on May 29, 2020 12:44pm
NVCN bankrupt soon
GLTA
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
A potential breakthrough in spinal cord and optic nerve injury treatment